Photodynamic therapy using a novel photosensitizer, TONS501, is similarly effective to ALA and EC036 photodynamic therapy on DMBA-and TPA-induced mouse skin papilloma

Journal of Dermatological Science

Volumn 66, Issue 3, 2012, Pages 221-224

  Takahashi, Hidetoshi ^a   Nakajima, Susumu ^b   Asano, Ryuji ^c   Nakae, Yoshinori ^c   Sakata, Isao ^c   Iizuka, Hajime ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b Moriyama Memorial Hospital   (Japan)

^c Photochemical Co Ltd   (Japan)

Author keywords

ALA; EC036; PDT; Skin tumor; TONS501

Indexed keywords

13,17 BIS(1 CARBOXYPROPIONYL)CARBAMOY( 3 METHYLPYRDINE) 3 (1,3 DIOXANE 2 YL)METHYLIDENE 8 ETHENYL 2 HYDROXY 2,7,12,18 TETRAMETHYL CHLORINE DIN METHYL IODIDE; 13,17 BIS(1 CARBOXYPROPIONYL)CARBAMOYLETHYL 3 ETHENYL 2 HYDROXY 3 HYDROXYIMINOETHLIDINE 2,7,12,18 TETRAMETHYLPORPHYRIN SODIUM SALT; PHOTOSENSITIZING AGENT; TONS 501; TONS 504; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; DIODE LASER; DRUG EFFICACY; DRUG POTENCY; FEMALE; LOTION; MOUSE; NONHUMAN; OINTMENT; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SKIN PAPILLOMA; TREATMENT RESPONSE;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ADMINISTRATION, TOPICAL; AMINOLEVULINIC ACID; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; MICE; MICE, HAIRLESS; OINTMENTS; PAPILLOMA; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE; TREATMENT OUTCOME;

EID: 84861349081     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2012.02.005     Document Type: Article

References (12)

1. Kennedy J.C., Poittier R.H., Pross D.C. Photodynamic therapy with endogenous protoporphirin IX: basic principles and present clinical appearance. J Photochem Photobiol B Biol 1990, 6:143-148.
2. Fritsch C., Goerz G., Ruzicka T. Ohotodynamic therapy in dermatology. Arch Dermatol 1998, 134:207-214.
3. Kurwa H.A., Barlow R.J. The role of photodynamic therapy in dermatology. Clin Exp Dermatol 1999, 24:143-148.
4. Morton C.A., Brown S.B., Collins S., Ibbotson S., Jenkinson H., Kurwa H., et al. Guideline for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol 2002, 143:552-567.
5. Ormrod D., Javis B. Topical aminolevulinic acid HCl photodynamic therapy. Am J Clin Dermatol 2000, 1:133-139.
6. Tahahashi H., Nakajima S., Asano R., Nakae Y., Sakata I., Hajime Iizuka H. Photodynamic therapy using a novel photosensitizer, EC036, is more effective compared with ATX-S10(Na) photodynamic therapy. J Dermatol Sci 2009, 55:130-132.
7. Laudanska H., Lemancewicz A., Kretowska M., Reduta T., Laudanski T. Permiability of human skin to selected anions and cations: in vitro studies. Res Commun Mol Pathol Pharmacol 2002, 112:16-26.
8. Demidova T.N., Hamblin M.R. Photodynamic therapy targeted to pathogens. Int J Immunopathol Pharmacol 2004, 17:245-254.
9. Wolf P., Rieger E., Kerl H. Topical photodynamic therapy with endogeneous porphyrin after application of 5-aminolevulinic acid: an alternative treatment modality for solar keratosis, superficial squamous cell carcinoma, and basal cell carcinoma?. J Am Acad Dermatol 1993, 28:17-21.
10. Fijian S., Honigsmann H., Ortel B. Photodynamic therapy of epithelial skin tumors using delta-aminolevulinic acid and desferrioxamine. Br J Dermatol 1995, 133:282-288.
11. Calzavara-Pinton P.G. Repetitive photodynamic therapy with topical d-amonolevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumors. J Photochem Photobiol B 1995, 29:53-57.
12. Takahashi H., Nakajima S., Sakata I., Ishida-Yamamoto A., Iizuka H. Photodynamic therapy using a novel photosensitizer, ATX-S10(Na): comparative effect with 5-aminolevulinic acid on squamous cell carcinoma cell line, SCC15, ultraviolet B-induced skin tumors, and phorbol ester-induced hyperproliferative skin. Arch Dermatol Res 2005, 296:496-502.